![1]()
News
Pharmacologic and electrical cardioversion of acute Afib reduces hospital admissions
July 20, 2021
Is pharmacologic cardioversion and/or electrical cardioversion an appropriate initial management strategy for acute atrial fibrillation?
![1]()
News
DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry
July 16, 2021
Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.
News
Long-term outcome data suggest optimism for MIS-C patients
July 16, 2021
Most inflammatory and cardiac manifestations of multisystem inflammatory syndrome in children resolved by 9 months.
News
New details of myocarditis linked to COVID vaccines
July 2, 2021
Further details from multiple cases of myocarditis linked to the Pfizer and Moderna mRNA COVID vaccines have been described in recent papers in the medical literature.
![1]()
News
Abnormal exercise EKG in the setting of normal stress echo linked with increased CV risk
June 28, 2021
What is the significance of an abnormal exercise EKG with a normal stress echo?
![1]()
News
FDA to add myocarditis warning to mRNA COVID-19 vaccines
June 24, 2021
But a CDC advisory panel, where the FDA made the announcement, still strongly backs the vaccines’ benefits, which outweigh the rare risk for heart inflammation.
![1]()
News
Sotagliflozin use in T2D patients linked with posthospitalization benefits in analysis
June 23, 2021
The paper’s outcome measure may be a meaningful, patient-centered way of capturing disease burden, according to the authors.
News
Prophylactic anticoagulation tied to lower death rate in COVID
June 18, 2021
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.
News
U.S., international MIS-C studies yield disparate results
June 18, 2021
The two real-world observational studies were published online in The New England Journal of Medicine.
News
Reversal agents curb DOAC-related bleeding but deaths still high
June 17, 2021
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
